ABVC BIOPHARMA, INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Dr. Richard King, the Company’s Chief Scientific Officer (“CSO”) of ABVC BioPharma, Inc. (the “Company”), notified the Company of his resignation, effective June 13, 2023.
The Company’s board of directors appointed Dr. Tsung-Shann (T.S.) Jiang to replace Dr. King as the Company’s CSO.
Extracted from this filing and checked against the source text.
Dr. Richard King resigned as Chief Scientific Officer at ABVC BIOPHARMA, INC..
Dr. Richard King, the Company’s Chief Scientific Officer (“CSO”) of ABVC BioPharma, Inc. (the “Company”), notified the Company of his resignation, effective June 13, 2023.View on SEC.gov
Dr. Tsung-Shann (T.S.) Jiang was appointed as Chief Scientific Officer at ABVC BIOPHARMA, INC..
The Company’s board of directors appointed Dr. Tsung-Shann (T.S.) Jiang to replace Dr. King as the Company’s CSO.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.